We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-3.11%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$21.4B
AUM Growth
-$526M
(-2.4%)
Cap. Flow
+$279M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
19.79%
Holding
3,307
New
142
Increased
1,419
Reduced
1,480
Closed
171
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$69.3M |
| 2 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$53.6M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$33.8M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$32.8M |
| 5 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$46.5M |
| 2 |
iShares Core S&P US Value ETF
IUSV
|
+$40.4M |
| 3 |
iShares Core S&P US Growth ETF
IUSG
|
+$28.7M |
| 4 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$23.5M |
| 5 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$23.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.11% |
| 2 | Financials | 4.79% |
| 3 | Consumer Discretionary | 4.07% |
| 4 | Healthcare | 3.88% |
| 5 | Industrials | 2.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAGE
2851
Niagen Bioscience
NAGE
$240M
| $179K | ﹤0.01% |
122,918
-25,425
| -17% | -$39.7K |
|
2852
Franklin FTSE China ETF
FLCH
$329M
| $178K | ﹤0.01% |
+10,444
| New | +$186K |
|
|
ZYXI
2853
DELISTED
Zynex
ZYXI
| $178K | ﹤0.01% |
22,188
-261,637
| -92% | -$2.19M |
|
2854
Amplify Seymour Cannabis ETF
CNBS
$76.5M
| $177K | ﹤0.01% |
3,065
+457
| +18% | +$23.6K |
|
2855
BlackRock Debt Strategies Fund
DSU
$599M
| $177K | ﹤0.01% |
17,275
| – | – |
|
|
SDHY
2856
PGIM Short Duration High Yield Opportunities Fund
SDHY
$399M
| $177K | ﹤0.01% |
12,191
+563
| +5% | +$8.48K |
|
|
ME
2857
DELISTED
23andMe Holding Co
ME
| $177K | ﹤0.01% |
9,047
-1,888
| -17% | -$52.9K |
|
2858
Nuveen Credit Strategies Income Fund
JQC
$717M
| $175K | ﹤0.01% |
34,505
-9,956
| -22% | -$50.5K |
|
|
OXLC
2859
Oxford Lane Capital
OXLC
$957M
| $175K | ﹤0.01% |
7,005
+61
| +0.9% | +$1.57K |
|
2860
Under Armour Class C
UA
$2.23B
| $175K | ﹤0.01% |
27,506
+1,386
| +5% | +$9.55K |
|
|
PACW
2861
DELISTED
PacWest Bancorp
PACW
| $175K | ﹤0.01% |
22,178
-6,657
| -23% | -$55.5K |
|
2862
Northwest Bancshares
NWBI
$2.32B
| $174K | ﹤0.01% |
17,021
+4,945
| +41% | +$55.2K |
|
2863
MasterBrand
MBC
$1.89B
| $173K | ﹤0.01% |
14,241
-1,561
| -10% | -$19.1K |
|
|
CTO
2864
CTO Realty Growth
CTO
$825M
| $172K | ﹤0.01% |
10,593
-2,520
| -19% | -$43.3K |
|
|
GLV
2865
Clough Global Dividend & Income Fund
GLV
$78.7M
| $172K | ﹤0.01% |
34,648
+2,325
| +7% | +$12.7K |
|
2866
Stem
STEM
$55.4M
| $172K | ﹤0.01% |
2,033
-442
| -18% | -$50.5K |
|
|
MTTR
2867
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $172K | ﹤0.01% |
79,137
-5,729
| -7% | -$16.1K |
|
2868
Coeur Mining
CDE
$18.7B
| $169K | ﹤0.01% |
76,253
+44,690
| +142% | +$117K |
|
2869
Lumen
LUMN
$6.45B
| $169K | ﹤0.01% |
119,250
-4,503
| -4% | -$7.62K |
|
2870
iQIYI
IQ
$1.27B
| $168K | ﹤0.01% |
35,423
+9
| +0% | +$47 |
|
|
FLNA
2871
Filana Therapeutics
FLNA
$45.3M
| $167K | ﹤0.01% |
10,026
-1,940
| -16% | -$38.4K |
|
|
DCF
2872
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
| $166K | ﹤0.01% |
21,347
+202
| +1% | +$1.56K |
|
2873
Pitney Bowes
PBI
$2.3B
| $165K | ﹤0.01% |
54,538
+2,618
| +5% | +$8.97K |
|
|
PMX
2874
DELISTED
PIMCO Municipal Income Fund III
PMX
| $164K | ﹤0.01% |
25,318
-800
| -3% | -$5.99K |
|
2875
Alger Mid Cap 40 ETF
FRTY
$153M
| $163K | ﹤0.01% |
13,451
-417
| -3% | -$5.29K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Cambridge Investment Research Advisors held 3,307 positions worth $21.4B, down 2.4% from $21.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors's Q3 2023 filing shows 142 new, 1,419 increased, 1,480 reduced and 171 closed positions. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 139,542 shares worth $6.12M. The largest sale was Vanguard Short-Term Corporate Bond ETF, an estimated $46.5M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q3 2023 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 139,542 shares worth $6.12M.
- Cambridge Investment Research Advisors added most to iShares 0-1 Year Treasury Bond ETF in Q3 2023, an estimated $69.3M increase.
- Cambridge Investment Research Advisors's biggest Q3 2023 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $46.5M.
- Cambridge Investment Research Advisors fully exited Invesco S&P SmallCap Quality ETF in Q3 2023, selling an estimated $4.88M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $21.4B portfolio in Q3 2023.
- Cambridge Investment Research Advisors opened 142 new positions and closed 171 in Q3 2023.
- Cambridge Investment Research Advisors's portfolio value fell 2.4% quarter-over-quarter to $21.4B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.